Suntrust Banks’s NxStage Medical Inc. NXTM Stock Holding History

Suntrust Banks’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-9,271	Closed	-$242K	–	1577
2016 Q4	$242K	Buy	+9,271	New	+$229K	﹤0.01%	1387

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Suntrust Banks's NXTM Position: Q1 2017 in Review

Suntrust Banks sold out of NxStage Medical Inc. (NXTM) in Q1 2017, closing a stake of 9,271 shares — an estimated $242K sold.

Suntrust Banks first reported a position in NXTM in Q4 2016 and held it in 1 quarter. The position peaked at $242K in Q4 2016. 171 funds tracked by Wall St. Rank hold NXTM as of Q1 2017.

Suntrust Banks reported no remaining NxStage Medical Inc. position as of Q1 2017 after selling out during the quarter.
Suntrust Banks sold 9,271 NxStage Medical Inc. shares in Q1 2017, an estimated $242K.
Suntrust Banks first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 1 quarter.
Suntrust Banks's NxStage Medical Inc. position peaked at $242K in Q4 2016.
171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2017.

Based on Suntrust Banks's 13F filing for Q1 2017, filed 3 May 2017.